Improving medication adherence in hypercholesterolemia: challenges and solutions

References

• National Center for Health StatisticsHealth, United States, 2012: With Special Feature on Emergency CareHyattsville, MDU.S. Department of Health and Human Services2013 Available from: http://www.cdc.gov/nchs/data/hus/hus12.pdf#065Accessed May 22, 2014
   Google Scholar
• RosamondWFlegalKFridayGAmerican Heart Association Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke statistics – 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics SubcommitteeCirculation20071155e69e17117194875
   PubMed Web of Science ®Google Scholar
• FryarCDChenTCLiXPrevalence of Uncontrolled Risk Factors for Cardiovascular Disease: United States, 1999–2010. NCHS Data Brief, Number 103Hyattsville, MDNational Center for Health Statistics2012
   Google Scholar
• OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
   PubMed Web of Science ®Google Scholar
• IMS Institute for Healthcare InformaticsAvoidable Costs in US Healthcare: The $200 Billion Opportunity from Using Medicines More ResponsiblyParsippany, NJIMS Institute for Healthcare Informatics2013
   Google Scholar
• SokolMCMcGuiganKAVerbruggeRREpsteinRSImpact of medication adherence on hospitalization risk and healthcare costMed Care200543652153015908846
   PubMed Web of Science ®Google Scholar
• National Center for Health StatisticsHealth, United States, 2010: With Special Feature on Death and DyingHyattsville, MDUS Department of Health and Human Services2011
   Google Scholar
• GoASMozaffarianDRogerVLAmerican Heart Association Statistics Committee and Stroke Statistics SubcommitteeExecutive summary: heart disease and stroke statistics – 2013 update: a report from the American Heart AssociationCirculation2013127114315223283859
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC)Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol – United States, 1999–2002 and 2005–200MMWR Morb Mortal Wkly Rep201160410911421293326
   PubMedGoogle Scholar
• GamboaCMSaffordMMLevitanEBStatin underuse and low prevalence of LDL-C control among US adults at high risk of coronary heart diseaseAm J Med Sci2014348210811424892511
   PubMed Web of Science ®Google Scholar
• KochanekKDXuJMurphySLMiniñoAMKungHCDeaths: Final Data for 2009. National Vital Statistics Reports603Hyattsville, MDNational Center for Health Statistics2012
   Google Scholar
• Centers for Disease Control and PreventionNational Ambulatory Medical Care Survey: 2009 Summary TablesAtlanta, GACenters for Disease Control and Prevention2009 Available from: http://www.cdcgov/nchs/data/ahcd/namcs_summary/2009_namcs_web_tables.pdfAccessed June 16, 2014
   Google Scholar
• KuklinaEVCarrollMDShawKMHirschRTrends in High LDL Cholesterol, Cholesterol-Lowering Medication Use, and Dietary Saturated-Fat Intake: United States, 1976–2010. NCHS Data Brief, Number 117Hyattsville, MDNational Center for Health Statistics2013
   Google Scholar
• HeidenreichPATrogdonJGKhavjouOAAmerican Heart Association Advocacy Coordinating CommitteeStroke Council; Council on Cardiovascular Radiology and InterventionCouncil on Clinical CardiologyCouncil on Epidemiology and PreventionCouncil on Arteriosclerosis; Thrombosis and Vascular BiologyCouncil on CardiopulmonaryCritical Care; Perioperative and ResuscitationCouncil on Cardiovascular NursingCouncil on the Kidney in Cardiovascular DiseaseCouncil on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes ResearchForecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart AssociationCirculation2011123893394421262990
   PubMed Web of Science ®Google Scholar
• KrumholzHMThe new cholesterol and blood pressure guidelines: perspective on the path forwardJAMA2014311141403140524682222
   PubMed Web of Science ®Google Scholar
• MartinSSBlumenthalRSConcepts and controversies: the 2013 American College of Cardiology/American Heart Association risk assessment and cholesterol treatment guidelinesAnn Intern Med2014160535635824473832
   PubMed Web of Science ®Google Scholar
• KavousiMLeeningMJNanchenDComparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohortJAMA2014311141416142324681960
   PubMed Web of Science ®Google Scholar
• PencinaMJNavar-BogganAMD’AgostinoRBApplication of new cholesterol guidelines to a population-based sampleN Engl J Med2014370151422143124645848
   PubMed Web of Science ®Google Scholar
• ReinerZCatapanoALDe BackerGEuropean Association for Cardiovascular Prevention and RehabilitationESC Committee for Practice Guidelines (CPG) 2008–2010 and 2010–2012 CommitteesESC/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)Eur Heart J201132141769181821712404
   PubMed Web of Science ®Google Scholar
• PerkJDe BackerGGohlkeHEuropean Association for Cardiovascular Prevention and Rehabilitation (EACPR)ESC Committee for Practice Guidelines (CPG)European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)Eur Heart J201233131635170122555213
   PubMed Web of Science ®Google Scholar
• TaylorFHuffmanMDMacedoAFStatins for the primary prevention of cardiovascular diseaseCochrane Database Syst Rev20131CD00481623440795
   PubMed Web of Science ®Google Scholar
• MuntnerPColantonioLDCushmanMValidation of the atherosclerotic cardiovascular disease Pooled Cohort risk equationsJAMA2014311141406141524682252
   PubMed Web of Science ®Google Scholar
• ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research GroupThe Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)JAMA2002288232998300712479764
   PubMed Web of Science ®Google Scholar
• Do statins have a role in primary prevention? An updateTherapeutics Letter201077 Letter 48
   Google Scholar
• MihaylovaBEmbersonJBlackwellLCholesterol Treatment Trialists’ (CTT) CollaboratorsThe effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trialsLancet2012380984158159022607822
   PubMed Web of Science ®Google Scholar
• KatzDHIntwalaSSStoneNJAddressing statin adverse effects in the clinic: The 5 MsJ Cardiovasc Pharmacol Ther Epub4252014
   PubMed Web of Science ®Google Scholar
• CramerJABenedictAMuszbekNKeskinaslanAKhanZMThe significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a reviewInt J Clin Pract2008621768717983433
   PubMed Web of Science ®Google Scholar
• HuserMAEvansTSBergerVMedication adherence trends with statinsAdv Ther200522216317116020406
   PubMed Web of Science ®Google Scholar
• GibsonTBFendrickAMGatwoodJChernewMEGaps in treatment, treatment resumption, and cost sharingAm J Pharm Benefits20124e159e165
   Google Scholar
• ChapmanRHBennerJSPetrillaAAPredictors of adherence with antihypertensive and lipid-lowering therapyArch Intern Med2005165101147115215911728
   PubMedGoogle Scholar
• SchultzJSO’DonnellJCMcDonoughKLSasaneRMeyerJDeterminants of compliance with statin therapy and low-density lipoprotein cholesterol goal attainment in a managed care populationAm J Manag Care200511530631215898219
   PubMed Web of Science ®Google Scholar
• BrookhartMAPatrickARSchneeweissSPhysician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin useArch Intern Med2007167884785217452550
   PubMedGoogle Scholar
• JackeviciusCALiPTuJVPrevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarctionCirculation200811781028103618299512
   PubMed Web of Science ®Google Scholar
• HoPMSpertusJAMasoudiFAImpact of medication therapy discontinuation on mortality after myocardial infarctionArch Intern Med2006166171842184717000940
   PubMedGoogle Scholar
• KopjarBSalesAEPiñerosSLSunHLiYFHedeenANAdherence with statin therapy in secondary prevention of coronary heart disease in veterans administration male populationAm J Cardiol20039291106110814583366
   PubMed Web of Science ®Google Scholar
• DiMatteoMRGiordaniPJLepperHSCroghanTWPatient adherence and medical treatment outcomes: a meta-analysisMed Care200240979481112218770
   PubMed Web of Science ®Google Scholar
• RasmussenJNChongAAlterDARelationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarctionJAMA2007297217718617213401
   PubMed Web of Science ®Google Scholar
• HoPMMagidDJShetterlySMMedication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery diseaseAm Heart J2008155477277918371492
   PubMed Web of Science ®Google Scholar
• WeiLWangJThompsonPWongSStruthersADMacDonaldTMAdherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up studyHeart200288322923312181210
   PubMed Web of Science ®Google Scholar
• PittmanDGChenWBowlinSJFoodyJMAdherence to statins, subsequent healthcare costs, and cardiovascular hospitalizationsAm J Cardiol2011107111662166621439533
   PubMed Web of Science ®Google Scholar
• ChanDCShrankWHCutlerDPatient, physician, and payment predictors of statin adherenceMed Care201048319620219890219
   PubMed Web of Science ®Google Scholar
• NewbyLKLaPointeNMChenAYLong-term adherence to evidence-based secondary prevention therapies in coronary artery diseaseCirculation2006113220321216401776
   PubMed Web of Science ®Google Scholar
• KiortsisDNGiralPBruckertETurpinGFactors associated with low compliance with lipid-lowering drugs in hyperlipidemic patientsJ Clin Pharm Ther200025644545111123498
   PubMed Web of Science ®Google Scholar
• ChapmanRHPetrillaAABennerJSSchwartzJSTangSSPredictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults: a retrospective, cohort studyDrugs Aging2008251088589218808213
   PubMed Web of Science ®Google Scholar
• HoPMRumsfeldJSMasoudiFAEffect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitusArch Intern Med2006166171836184117000939
   PubMed Web of Science ®Google Scholar
• FaulknerMAWadibiaECLucasBDHillemanDEImpact of pharmacy counseling on compliance and effectiveness of combination lipid- lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trialPharmacotherapy200020441041610772372
   PubMed Web of Science ®Google Scholar
• PostonJLohEDunhamWThe medication use studyCan Pharm J1998131103138
   Google Scholar
• VrijensBBelmansAMatthysKde KlerkELesaffreEEffect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatinPharmacoepidemiol Drug Saf200615211512116342302
   PubMed Web of Science ®Google Scholar
• LeeJKGraceKATaylorAJEffect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trialJAMA2006296212563257117101639
   PubMed Web of Science ®Google Scholar
• TaitelMJiangJRudkinKEwingSDuncanIThe impact of pharmacist face-to-face counseling to improve medication adherence among patients initiating statin therapyPatient Prefer Adherence2012632332922563240
   PubMed Web of Science ®Google Scholar
• PetersonGMFitzmauriceKDNauntonMVialJHStewartKKrumHImpact of pharmacist-conducted home visits on the outcomes of lipid-lowering drug therapyJ Clin Pharm Ther2004291233014748894
   PubMed Web of Science ®Google Scholar
• Márquez ContrerasECasado MartínezJJCorchado AlbalatYEfficacy of an intervention to improve treatment compliance in hyperlipidemiasAten Primaria2004338443450 Spanish15151791
   PubMedGoogle Scholar
• Márquez ContrerasECasado MartínezJJMotero CarrascoJTherapy compliance in cases of hyperlipaemia, as measured through electronic monitors. Is a reminder calendar to avoid forgetfulness effective?Aten Primaria20073912661668 Spanish18093505
   PubMed Web of Science ®Google Scholar
• GuthrieRMThe effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the first myocardial infarction risk reduction programClin Ther200123697098011440296
   PubMed Web of Science ®Google Scholar
• SchectmanGHiattJHartzATelephone contacts do not improve adherence to niacin or bile acid sequestrant therapyAnn Pharmacother199428129358123955
   PubMed Web of Science ®Google Scholar
• JohnsonSSDriskellMMJohnsonJLTranstheoretical model intervention for adherence to lipid-lowering drugsDis Manag20069210211416620196
   PubMedGoogle Scholar
• BrownBGBardsleyJPoulinDModerate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low-density lipoprotein cholesterol ,100 mg/dL in patients with hyperlipidemia and coronary artery diseaseAm J Cardiol19978021111159230143
   PubMed Web of Science ®Google Scholar
• TamblynREgualeTHuangAWinsladeNDoranPThe incidence and determinants of primary nonadherence with prescribed medication in primary care: a cohort studyAnn Intern Med2014160744145024687067
   PubMed Web of Science ®Google Scholar
• EaddyMTCookCLO’DayKBurchSPCantrellCRHow patient cost-sharing trends affect adherence and outcomes: a literature reviewP T2012371455522346336
   PubMedGoogle Scholar
• WatanabeJHKazerooniRBounthavongMAssociation of copayment with likelihood and level of adherence in new users of statins: a retrospective cohort studyJ Manag Care Pharm2014201435024372459
   PubMed Web of Science ®Google Scholar
• ChoudhryNKAvornJGlynnRJPost-Myocardial Infarction Free Rx Event and Economic Evaluation (MI FREEE) TrialFull coverage for preventive medications after myocardial infarctionN Engl J Med2011365222088209722080794
   PubMed Web of Science ®Google Scholar
• BhargavaVGregMEShieldsMCAddition of generic medication vouchers to a pharmacist academic detailing program: effects on the generic dispensing ratio in a physician-hospital organizationJ Manag Care Pharm201016638439220635829
   PubMed Web of Science ®Google Scholar
• GilmoreASZhaoYKangNPatient outcomes and evidence-based medicine in a preferred provider organization setting: a six-year evaluation of a physician pay-for-performance programHealth Serv Res2007426 Pt 121402159 discussion 2294–232317995557
   PubMed Web of Science ®Google Scholar
• FjeldsoeBSMarshallALMillerYDBehavior change interventions delivered by mobile telephone short-message serviceAm J Prev Med200936216517319135907
   PubMed Web of Science ®Google Scholar
• KrishnaSBorenSABalasEAHealthcare via cell phones: a systematic reviewTelemed J E Health200915323124019382860
   PubMed Web of Science ®Google Scholar
• WeiJHollinIKachnowskiSA review of the use of mobile phone text messaging in clinical and healthy behaviour interventionsJ Telemed Telecare2011171414821097565
   PubMed Web of Science ®Google Scholar
• EllisSLCarterBLMaloneDCClinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical CentersPharmacotherapy200020121508151611130223
   PubMed Web of Science ®Google Scholar
• BeckerDMAllenJKImproving compliance in your dyslipidemic patient: an evidence-based approachJ Am Acad Nurse Pract200113520020711930470
   PubMedGoogle Scholar
• AllenJKBlumenthalRSMargolisSYoungDRMillerERKellyKNurse case management of hypercholesterolemia in patients with coronary heart disease: results of a randomized clinical trialAm Heart J2002144467868612360165
   PubMed Web of Science ®Google Scholar
• CosgroveDMFisherMGabowPTen strategies to lower costs, improve quality, and engage patients: the view from leading health system CEOsHealth Aff (Millwood)201332232132723381525
   PubMed Web of Science ®Google Scholar
• BodenheimerTWagnerEHGrumbachKImproving primary care for patients with chronic illness: the chronic care model, Part 2JAMA2002288151909191412377092
   PubMed Web of Science ®Google Scholar
• WardMMAccess to care and the incidence of end-stage renal disease due to diabetesDiabetes Care20093261032103619460914
   PubMed Web of Science ®Google Scholar
• JacksonGLPowersBJChatterjeeRImproving patient care. The patient centered medical home. A Systematic ReviewAnn Intern Med2013158316917824779044
   PubMed Web of Science ®Google Scholar
• DominoMEHumbleCLawrenceWWWegnerSEnhancing the medical homes model for children with asthmaMed Care200947111113112019786921
   PubMed Web of Science ®Google Scholar
• BaileyJEWanJYTangJGhaniMACushmanWCAntihypertensive medication adherence, ambulatory visits, and risk of stroke and deathJ Gen Intern Med201025649550320165989
   PubMed Web of Science ®Google Scholar
• FerrajoloCArcoraciVSulloMGPattern of statin use in southern italian primary care: can prescription databases be used for monitoring long-term adherence to the treatment?PLoS One201497e10214625072244
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsExecutive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)JAMA2001285192486249711368702
   PubMed Web of Science ®Google Scholar
• GrundySMCleemanJIMerzCNNational Heart, Lung, and Blood InstituteAmerican College of Cardiology FoundationAmerican Heart AssociationImplications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesCirculation2004110222723915249516
   PubMed Web of Science ®Google Scholar
• GoffDCLloyd-JonesDMBennettG2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesCirculation201412925 Suppl 2S49S7324222018
   PubMed Web of Science ®Google Scholar
• StoneNJRobinsonJGLichtensteinAHAmerican College of Cardiology/American Heart Association Task Force on Practice Guidelines2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesJ Am Coll Cardiol20146325 Pt B2889293424239923
   PubMed Web of Science ®Google Scholar
• Risk assessment tool for estimating your 10-year risk of having a heart attack [webpage on the Internet]Bethesda, MDNational Heart, Lung, and Blood Institute2013 Available from: http://cvdrisk.nhlbi.nih.govAccessed October 14, 2014
   Google Scholar
• Pooled cohort risk assessment equations [webpage on the Internet]ChicagoClinCalc LLC2014 Available from: http://clincalc.com/Cardiology/ASCVD/PooledCohort.aspxAccessed October 14, 2014
   Google Scholar